Focus doesn't fail because you're not trying hard enough.

It fails because focus isn't a single thing. It's the output of several biological systems running simultaneously when any one of them drops, the whole engine degrades.

The Science

This formula operates on two primary mechanisms simultaneously — cholinergic function and catecholamine management — and the design logic is that each cluster handles a different failure mode of cognitive performance.

The cholinergic cluster is the centrepiece. Alpha-GPC at 100mg delivers choline directly into neurons as a phospholipid precursor, elevating acetylcholine synthesis. Huperzine-A at 4µg then inhibits acetylcholinesterase — the enzyme responsible for acetylcholine breakdown. These two ingredients don’t merely add to each other; they work at opposite ends of the same pathway. Alpha-GPC floods the pool. Huperzine-A slows the drain. The result is meaningfully elevated acetylcholine availability that neither could achieve as effectively alone. Phosphatidylserine at 150mg (standardised to 20%) supports membrane fluidity and receptor integrity at the synaptic interface — it’s the structural environment those elevated neurotransmitter levels need to function in.

The second cluster manages arousal and catecholamine dynamics. L-Tyrosine at 150mg is the direct precursor to dopamine, norepinephrine, and adrenaline — it replenishes the raw material for these systems under load. L-Theanine at 200mg is its essential counterpart: it promotes alpha-wave activity and attenuates the excitatory edge of catecholamine activity without suppressing it. High cognitive drive without anxiety is the target state — Tyrosine pushes toward that drive, Theanine shapes the quality of the arousal it produces. Oat Straw Extract at 100mg (70% beta-glucans) adds a third layer via PDE4 inhibition, which reduces the breakdown of cAMP — a second messenger that prolongs dopaminergic and noradrenergic signalling. This means the raw material Tyrosine provides, and the signal Theanine shapes, both last longer at the cellular level. 

Bacopa Monnieri at 40mg (50% Bacosides) sits outside these two clusters but integrates across both. Its primary mechanism involves modulating BDNF, supporting dendritic growth and synaptic plasticity — it’s the structural adaptability layer. Cat’s Claw at 80mg (5% alkaloids) contributes primarily through anti-inflammatory and neuroprotective mechanisms, clearing interference. 

As a branched-chain amino acid, L-Leucine’s presence is blood-brain barrier crossing facilitation role 

The overall design logic: the formula addresses acetylcholine availability, catecholamine quality, signal duration, and the structural environment of cognition simultaneously. No single cluster is sufficient alone. The combination targets why cognition fails under load — it’s not usually one thing.